Xponance’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
DTC
Xponance's GH Position: Q2 2026 in Review
Xponance increased its Guardant Health (GH) stake by 68% in Q2 2026, buying an estimated $867K and bringing the position to 19,621 shares worth $2.94M. The position accounts for 0.02% of the portfolio, ranked #504.
Xponance first reported a position in GH in Q2 2020 and has held it in 21 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Xponance held 19,621 shares of Guardant Health worth $2.94M as of Q2 2026.
- Xponance bought 7,971 Guardant Health shares in Q2 2026, an estimated $867K.
- Guardant Health made up 0.02% of Xponance's portfolio in Q2 2026, its #504 holding.
- Xponance first reported a position in Guardant Health in Q2 2020 and has held it in 21 quarters since.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.